Search

Search Constraints

You searched for: Author/Creator Dörfel, Steffen

Search Results

1. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020)

2. Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study. Issue 10 (October 2017)

3. PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer. Issue 7 (27th July 2021)

4. Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry. Issue 2 (2nd February 2023)

5. Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. Issue 6 (23rd October 2020)

6. Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. Issue 6 (23rd October 2020)

7. Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practice. (22nd March 2018)

8. Routine treatment of patients with chronic lymphocytic leukaemia by office‐based haematologists in Germany—data from the Prospective Tumour Registry Lymphatic Neoplasms†. Issue 1 (15th April 2014)

9. Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemia. Issue 12 (8th October 2021)